SKI Market

A+| A| A-|

Indian Indices

Sensex

77,496.36 609.45
( 0.79%)

Global Indices

Nasdaq

48,888.32 -274.62
(-0.56%)

Dow Jones

7,157.73 -2.07
(-0.03%)

Hang Seng

59,839.06 -698.30
(-1.15%)

Nikkei 225

10,208.73 -124.06
(-1.20%)

Forex

USD-INR

94.18 0.27
(0.28%)

EUR-INR

110.46 0.44
(0.40%)

GBP-INR

127.53 0.53
(0.42%)

JPY-INR

0.59 0.00
(0.34%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vivimed Labs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532660

INE526G01021

0.9167078

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VIVIMEDLAB

56.38

EPS(TTM)

Face Value()

Div & Yield %

Back

IRIS Business Services consolidated net profit rises 2935.06% in the September 2025 quarter

Nov 15,2025

Net profit of IRIS Business Services rose 2935.06% to Rs 116.85 crore in the quarter ended September 2025 as against Rs 3.85 crore during the previous quarter ended September 2024. Sales rose 6.13% to Rs 28.56 crore in the quarter ended September 2025 as against Rs 26.91 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	28.56	26.91	6
OPM %	0.53	17.58	-
PBDT	2.60	5.20	-50
PBT	2.10	4.83	-57
NP	116.85	3.85	2935

77,496.36 609.45 ( 0.79%)

48,888.32 -274.62 (-0.56%)

7,157.73 -2.07 (-0.03%)

59,839.06 -698.30 (-1.15%)

10,208.73 -124.06 (-1.20%)

94.18 0.27 (0.28%)

110.46 0.44 (0.40%)

127.53 0.53 (0.42%)

0.59 0.00 (0.34%)